National Health Executive| Published online: 14 October 2016
It could be harder for some treatments to become available on the NHS if they are found to be too costly, under new proposals.
NHS England and NICE have opened a joint consultation on proposals to introduce a £20m budget threshold, which is thought to apply to around 20% of treatments.
Where a new treatment is expected to exceed the threshold, NHS England would seek a special commercial agreement with the company.
Sir Andrew Dillon, chief executive of NICE, said: “We want to be more agile and flexible in the way we make decisions about new drugs, medical devices and diagnostics, so that patients can get access to them more quickly and the NHS can manage its resources fairly and efficiently. NICE and NHS England have worked together to develop these proposals.
Read the full outline here